In today's Bitcoin crash, a new price floor was created for Bitcoin, and the created triangle proves my idea for an ascending target of up to $ 70,000.
As you know better. The price has dropped from $ 67,000 to $ 37,800. Of course, in the created triangle, there is a possibility of a price fall, which seems unlikely given the 48.80% fall of the previous price...
How far SHOP can go down? There will be a bounce ? If yes at what possible prices?
We accurately predicted the stock path several weeks ago by means of Elliott waves and called for a Big Shor t at ATH ! What is next?
Currently SHOP is in a MAJOR correction. SHOPIFY completed a primary degree wave cycle which was started at 18.48 USD on Jan 2016 at its ...
Bitcoin looks it could build an Head and Shoulder Patter which could bring the price hit 10.500$... Exactly where Volumes are the most (see in the chart the red line which is the point of control). Obviously it must first break the neckline.
If the price doesn't build the second shoulder and break directly the neckline, the target would be no more 10.500$ but...
Next upside Clone boundary target is around 55800 and an intermediate upside target of 50600, a short term retrace could see price down to bottom of current Clone boundary or to top of channel
CALL TYPE : #SHORTTERM
BUY AROUND/BTW : 0.00002700 -0.00002820
TARGETS
TARGET 1 : 0.00002970 (10.00%)
TARGET 2 : 0.00003143 (16%)
TARGET 3 : 0.00003566 (32%)
STOPLOSS : 0.00002600
ALL INDICATORS BULLISH. BUY & HOLD FOR FEW DAYS FOR GOOD PROFIT. ATLS WILL SHOW SOME RALLY TOO. #ENJ IS AT BREAKOUT
Bakkt Holdings, Inc. operates a digital asset platform. Its platform enables consumers to buy, sell, store, and spend digital assets. The company was founded in 2018 and is headquartered in Atlanta, Georgia. Bakkt Holdings, Inc. is a subsidiary of Intercontinental Exchange Holdings, Inc.
Heading down towards the previous support level of 0,82307. Lets see if we can hold that level and bounce back up towards the 0.382 fibonacci level of 0,91932. We also formed a death cross so not looking good at the shorter timeframe. On the otherhand the RSI is hitting the bottom of the zone so is looking for a bounce. Getting some mixed messages! Let me know...
ADDvantage Technologies Reports 61% Revenue Growth for the Fourth Quarter of Fiscal 2021
ADDvantage Technologies Group, Inc., through its subsidiaries, distributes and services electronics and hardware for the telecommunications industry in the United States, Canada, Central America, Asia, Europe, Mexico, South America, and internationally. The company operates...
Hey guys!
Our weekly target of 16696 was hit on Monday itself due to a gap down and fall in nifty.
Yesterday and today, the markets have recovered and started the move from swing low to swing high. Therefore, the expectation tomorrow is bullish with a target of 17024 and 17170 after which nifty has the decide the direction.
However, the trenline is important...
Traders,
Those of you who are my paid substack subs know that I stopped out of Jasmy a week or so ago. I have since been looking for a new area to re-enter. I believe we are near our new target down. I have placed a buy limit at .0737 cents.
Swing targets remain .27/.28 cents up to .39 cents.
I hope to capture my buy price tonight or tomorrow night. If I don't...
Hi Traders,
A non-video post for you all here.
Bitcoin, under the ascending BLACK trendline, has now entered into bearish territory. But, as I have explained numerous times throughout my daily update videos, I do NOT think this is the beginning of a longer-term bear market. This, quite simply, is a pull-back that may last for a few more weeks or through mid/end...
PetVivo shares are trading higher after ThinkEquity initiated coverage on the stock with a Buy rating and a $7 price target.
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is...
HC Wainwright & Co. Assumes VYNE Therapeutics at Buy, Announces Price Target of $7
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in...
Guggenheim Maintains Buy on Adicet Bio, Raises Price Target to $32
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting,...
This will take time, but in next 100 days this target would be CHECKED!
If you have #luna just fallow it with a safe SL and let it grow to where it can go!
PLZ manage Your Capital And RISK!
In this video:
* We discuss the area of entry (our target down) which we have reached
* We discuss entry strategy
* We discuss our final target of $2.10 - $2.50 for Basic Attention Token.
